Pituitary Tumor FAQ
Pituitary Tumor FAQ
The questions on this page come after the medical ones have been answered — what treatment will cost, how long the patient will be away from home, which medicines are available here, and what happens on return. They are answered separately on purpose, because this is a condition managed over years rather than treated once, and knowing which part has to happen where is what makes the arrangements workable.
What treatment costs
Treatment in China typically costs 30% to 50% of the equivalent in Europe or the United States. The total depends on which parts of the pathway you need:
- Imaging and hormone assessment — a dedicated pituitary MRI with contrast, the full hormone panel including any dynamic tests, and formal visual field testing.
- Medication, where medication is the treatment — dopamine agonists, somatostatin analogues or agents that control cortisol — which is a continuing cost measured in months and years rather than a single episode.
- Transsphenoidal surgery — the operation itself, the endoscopic equipment and monitoring it requires, and the hospital stay around it.
- Radiation, where it is used — stereotactic radiosurgery or fractionated treatment, planned around the residual tumour and the optic chiasm.
- Hormone replacement — cortisol, thyroid hormone, sex hormones and desmopressin where they are needed; these continue after treatment and are costed as ongoing medication.
- Rehabilitation and supportive care — neuro-ophthalmology follow-up where vision is affected, assessment and treatment where fertility is involved, and the ordinary recovery after surgery through the nose.
How long you will need to stay
The length of a stay is determined by which part of the treatment you are in:
- Assessment and planning — usually about one week, including the dedicated MRI protocol, the hormone panel with any timed tests, and the visual fields.
- Transsphenoidal surgery — usually about a week in hospital, including the hormone testing afterwards, which is the part of the stay that most often sets the date of discharge.
- Medication-led treatment — no surgical stay; the starting dose is set and the first hormone results are reviewed, and the rest of the monitoring happens at home.
- Radiation — stereotactic radiosurgery is generally a short outpatient visit; fractionated treatment involves a series of visits across consecutive days, arranged in advance.
- Observation alone — no stay at all; the schedule for hormones, imaging and visual fields is set out, and the first comparison is made from home.
- Follow-up — hormone, imaging and visual field checks at intervals, which can be done locally with the results sent to us for comparison.
Which medicines are available
The medicines used here fall into three groups, and it is worth asking about each separately:
- Medicines that lower a hormone. Dopamine agonists for prolactin, somatostatin analogues for growth hormone, and agents that reduce cortisol production in Cushing's disease. Several of these are available in China, and the specific product should be confirmed in writing for your case rather than assumed from a general list, because availability of individual agents can change.
- Replacement hormones. Cortisol, thyroid hormone, sex hormones, growth hormone in selected adults and desmopressin. These are ordinary maintained medicines, and the practical questions are the dose, how it changes during illness, and how to obtain the same product at home.
- Supportive medicines. Pain relief while the nose heals after transsphenoidal surgery, and treatment where headache persists; both are planned around the other medicines the patient is taking.
Sending records and receiving a written opinion
The most useful thing to send is the original documents and the images rather than a summary:
- The MRI images themselves, or a link to them, for every scan that has been done. The comparison between studies is what decides whether treatment is needed, and it can only be made on the images.
- The hormone results, with the reference ranges of the laboratory that performed them, and the dates they were taken. A number without its range and date cannot be interpreted reliably.
- The visual field printouts, not a description of them, since the printed record is what can be compared later.
- The operative record stating the approach, the extent of removal and the pathology type, if surgery has been performed.
- The radiotherapy record with the dose and the volumes treated, if radiation has been given.
- The current medication list, including replacement hormones and their doses, together with a note of how the symptoms have changed over time.
Insurance and payment
Coverage needs checking in specific terms, because this pathway includes both a surgical episode and continuing medication:
- Check whether the policy covers treatment outside your country of residence before assuming it does, and whether prior authorisation is required for each phase separately.
- Check surgical cover specifically, since transsphenoidal surgery in this region carries different coding from routine procedures, and the hormone testing around it is part of the episode.
- Check cover for radiation where it is planned, as some policies treat radiosurgery as a specialised technique requiring separate approval, or exclude it.
- Check cover for continuing medication — the dopamine agonists, somatostatin analogues, cortisol replacement and other maintenance medicines are a recurring cost rather than a single expense, and continuing supply at home is often overlooked until it becomes urgent.
- Check cover for the follow-up hormone tests and imaging that continue for years, including the visual field tests; these are separate claims under many policies.
- Ask whether direct billing is available for your insurer, and request the documentation they need at the outset — a treatment plan, an itemised estimate and clinical justification take time to assemble.
After treatment, and back home
Because this condition is followed for years, the handover document matters as much as the treatment record:
- A written summary of what was actually done — the operation with its approach and extent of removal, or the radiation with its dose, or the medicine with its starting dose, together with the pathology type where tissue was obtained.
- A schedule with dates for hormone tests, imaging and visual field tests, stating when each is next due, how the intervals widen, and what change would prompt an earlier test.
- The replacement hormone plan in writing — which hormones, at what doses, how the cortisol dose is increased during illness or before an operation, and what to do if a dose is missed.
- The hormone results at discharge, with reference ranges, as the baseline against which later results are compared.
- A rehabilitation and follow-up plan to continue locally — neuro-ophthalmology where vision was affected, and fertility follow-up where it is relevant, with the goals stated.
- A named contact for questions between tests, and the arrangement for images, hormone results and field printouts taken locally to be reviewed remotely.
Eating, activity and daily life
No diet treats a pituitary tumour. What nutrition and daily life can do is support you through treatment and protect what the hormones control:
- Weight stability and adequate protein — particularly important while taking hormone medication or while cortisol levels are being brought under control, because both appetite and blood sugar are affected.
- Bone protection where sex hormones or cortisol are involved — because these hormones affect bone density whether they are deficient or in excess, replacement is managed deliberately rather than left to drift.
- Returning to activity as tolerated after surgery — the usual advice while the surgical area heals, avoiding nose-blowing, straining and heavy lifting, then a gradual return to normal activity.
- Supplements discussed first — some interact with medication, so they are worth raising with the treating team rather than continuing independently.